Publications

2014 - 2013 - 2012 - 2011 - 2010

2014

Articles originaux publiés dans des journaux à politique éditoriale

  • Talabot-Ayer D., Martin P., Seemayer C.A., Vigne S., Lamacchia C., Finckh A., Saiji E., Gabay C., Palmer G.: Immune-mediated experimental arthritis in IL-33 deficient mice. Cytokine 2014; 69: 68-74
  • Bas S., Finckh A., Puskas G.J., Suva D., Hoffmeyer P., Gabay C., Lubbeke A.: Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop 2014; 38: 2577-83
  • Ciubotariu E., Gabay C., Finckh A.: Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs? J Rheumatol 2014; 41: 1576-82
  • Dennis Jr G., Holweg C.T.J., Kummerfeld S.K., Choy D.F., Setiadi F., Hackney J.A., Haverty P.M., Gilbert H., Lin W.Y., Diehl L., Fischer S., Song A., Musselman D., Klearman M., Gabay C., Kavanaugh A., Endres J., Fox D.A., Martin F., and Townsend M.J. : Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther 2014 ; 16 : R90
  • Nogueira L., Cornillet M., Singwe-Ngandeu M., Viatte S., Bas S., Gabay C., Serre G.: In black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides 36-50 Cit38, 42 and 60-74Cit60, 72, 74, like Caucasians. Clinical Immunol 2014; 152: 58-64
  • Nissen M., Boucher A., Brulhart L., Menetrey J., Gabay C. : Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour. Ann Rheum Dis 2014; 73 : 947-8 [IF 9.2]
  • Finckh A, Mc Carthy GM, Madigan A, Van Linthoudt D, Weber M, Neto D, Rappoport G, Blumhardt S, Kyburz D, Guerne PA. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized cross-over trial. Arthritis Res Ther. 2014 Oct 15;16(5):458 [IF: 4.12]
  • Talabot-Ayer D, Martin P, Seemayer CA, Vigne S, Lamacchia C, Finckh A, Saiji E, Gabay C and Palmer G. Immune-Mediated Experimental Arthritis in IL-33 deficient mice. Cytokine. 2014 Sep;69(1):68-74  [IF 3.12]
  • Emery P, Gottenberg JE, Rubbert-Roth A, Sarzi-Puttini P, Choquette D, (…) and Finckh A. Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis and an inadequate response to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Ann Rheum Dis. 2014 Jan 29 [IF 9.27]
  • Genevay S,  Marty M,  Courvoisier DS, Foltz V, Mahieu G, Demoulin C, Gierasimowicz Fontana A, Norberg M, de Goumoëns P,  Cedraschi C, Rozenberg S, Section Rachis de la Société Française de Rhumatologie
  • Validity of the French version of the Core Outcome Measures Index for low back pain patients: a prospective cohort study.Eur Spine J. 2014 Jul 15 [Epub ahead of print] [IF 2.133]
  • Armand S, Tavcar Z, Turcot K, Allet L, Hoffmeyer P, Genevay S
  • Effects of unstable shoes on chronic low back pain in health professionals: a randomized clinical trial. Joint Bone Spine.Joint Bone Spine. 2014 Jun 28. [IF 3.218]

 

2013

Articles originaux publiés dans des journaux à politique éditoriale

  • Zufferey P., Tamborrini G., Gabay C., Krebs A., Kyburz D., Michel B., Moser U., Villiger P., So A., Ziswiler H.R.: Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience. Swiss Med Wkly 2013; 143: w13861
  • Martin P., Palmer G., Vigne S., Lamacchia C., Rodriguez E., Talabot-Ayer D., Rose-John S., Chalaris A., Gabay C.: Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. J Leukoc Biol 2013; 94: 791-802
  • Lamacchia C., Rodriguez E., Palmer G., Gabay C.: Endogenous IL-1a is chromatin-associated protein in mouse macrophages. Cytokine 2013; 63: 135-144 [IF 3.2]
  • Lamacchia C., Palmer G., Rodriguez E., Martin P., Vigne S., Seemayer C.A., Talabot-Ayer D., Towne J.E., Gabay C.: The severity of experimental arthritis is independent of IL-36 receptor signaling. Arthritis Res Ther 2013; 15: R38 [IF 4.5]
  • Gabay C., Emery P., van Vollenhoven R., Dikranian A., Alten R., Pavelka K., Klearman M., Musselman D., Agarwal S., Green J., Kavanaugh A.: Tocilizumab monotherapy is Superior to adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis (ADACTA) : results from a randomized double-blind trial. Lancet 2013; 381: 1541-1550 [IF 38.2]
  • Martin P., Talabot-Ayer D., Seemayer C.A., Vigne S., Lamacchia C., Rodriguez E., Finckh A., Smith D.E., Gabay C., Palmer G.: Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis Res Ther 2013; 15: R13 [IF 4.5]
  • Möller B, Pruijm M, Adler S, Wisler D, Scherer A, Villiger PM, and Finckh A, on behalf of the SCQM. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis. 2013 Dec 19 [IF 9.11]
  • Möller B, Wisler D, Scherer A, Villiger PM & Finckh A. Anemia may add information to standardized disease activity assessment to predict radiographic damage in rheumatoid arthritis - a prospective cohort study. Ann Rheum Dis 2013; Mar 16; 72: [IF 9.11]
  • Steiner, A.S, Sartori, M.,  Leal, S., Kupper, D., Gallice, J.P., Rentsch, D., Cedraschi, C., Genevay, S. Added value of an intensive multidisciplinary functional rehabilitation programme for chronic low back pain patients. Swiss Medical Weekly 2013; 143: w13763
  • Steiner AS, Sartori M, Leal S, Kupper D, Gallice JP, Rentsch D, Cedraschi C, Genevay S.Added value of an intensive multidisciplinary functional rehabilitation program for chronic low back pain patients. Swiss Med. Wkly 2013 Mar 5;143 [IF 1.821]

Articles de revue dans des journaux à politique éditoriale

  • Kyburz D. and Finckh A."The importance of early treatment for the prognosis of rheumatoid arthritis" Swiss Med Weekly. Swiss Med Wkly. 2013; Sep 19;143:w13865 [IF 1.82]

 

2012

Articles originaux publiés dans des journaux à politique éditoriale

  • Courvoisier D, Agorisatas T, Glauser J, Michaud K, Wolfe K, Cantoni E, Pernegger T, Finckh A. Pain is the most important predictor of psychosocial health in patients with Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2012 Feb;64(2):190-6 [IF 4.851]. PMID: 21972106
  • Genevay S, Cedraschi C, Marty M, Rozenberg S, De Goumoens P, Faundez A, Balagué F, Porchet F, Mannion A.Reliability and validity of the cross-culturally adapted French version of the Core Outcome Measures Index (COMI) in patients with low back pain. Eur Spine J. Eur Spine J. 2012 Jan;21(1):130-7. [IF 2.133]
  • Viatte S., Flynn E., Lunt M., Barnes J., Singwe-Ngandeu M., Bas S., Barton A., Gabay C.: Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disase. Arthritis Res Ther 2012; 14: R239 [IF 4.5]
  • Vigne S., Palmer G., Martin P., Lamacchia C., Strebel D., Rodriguez E., Olleros M.L.,Gabay C.: IL-36 Signaling Amplifies Th1 Responses by Enhancing Proliferation and Th1 Polarization of Naïve CD4+ T cells. Blood 2012; 120: 3478-87 [IF 9.9]
  • Lamacchia C., Rodriguez E., Palmer G., Vesin C., Seemayer C.A., Rubbia-Brandt L., Gabay C.: Mice deficient in hepatocyte-specific interleukin-1 receptor agonist show delayed resolution of concanavalin A-induced hepatitis. Eur J Immunol. 2012;42: 1294-303 [IF 4.9]
  • Finckh A., Möller B., Dudler J., Walker U., Kyburz D., Gabay C.: Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Ann Rheum Dis 2012;71: 1680-5 [IF 9.1]
  • Finckh A., Courvoisier D., Pagano S, Bas S., Chevallier-Ruggeri P., Hochstrasser D., Roux-Lombard P., Gabay C., Vuilleumier N.: Evaluation of cardiovascular risk in Patients with Rheumatoid Arthritis. Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Arthritis Care Res 2012; 64:817-25 [4.7]
  • Martin de Pan S., Scherer A., Gabay C., Finckh A.: Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to a first anti-TNF agent in rheumatoid arthritis patients. Ann Rheum Dis 2012; 71:997-9 [IF 9.1]
  • Lamacchia C., Rodriguez E., Palmer G., Vigne S., Martin P., Talabot-Ayer D., Seemayer C.A., Gabay C.: Articular inflammation is controlled by myeloid cellderivedinterleukin-1 receptor antagonist during the acute phase of arthritis in mice. Ann Rheum Dis 2012; 71: 281-7 [9.1]
  • Genevay S., Finckh A., Zufferey P., Viatte S., Balagué F., Gabay C.: Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomized double-blind placebo-controlled trial. Ann Rheum Dis. 2012; 71:560-2 [IF 9.1]

Articles de revues publiés dans des journaux à politique éditoriale

  • Gabay O., Gabay C. : Hand osteoarthritis – New insights. Joint Bone Spine 2012 ;80 : 130-134 [IF 2.3]

 

2011

Articles originaux publiés dans des journaux à politique éditoriale

  • Talabot-Ayer D., Calo N., Vigne S., Lamacchia C., Gabay C., Palmer G.: The mouse interleukin-33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J Leukoc Biol. 2011; 91: 119-125 [IF 4.6], PMID : 22013230
  • Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE, Gabay C. : IL-36R ligands are potent regulators of dendritic and T cells. Blood. 2011; 118 : 5813-23 [IF 10.6], PMID : 21860022
  • Waldburger J-M., Palmer G., Seemayer C., Lamacchia C., Finckh A., Christofilopoulos P., Baeten D., Reith W., Gabay C.: Autoimmunity and inflammation are independent of CIITA pIV dependent MHCII expression in peripheral tissues during collagen induced arthritis. Arthritis Rheum. 2011; 63 : 3354-63 [IF 8.4], PMID : 21739421
  • Gabay C., Medinger-Sadowski C., Gascon D., Kolo F., Finckh A.: Symptomatic effect of chondroitin sulfate 4&6 in hand osteoarthritis. The finger osteoarthritis chondroitin treatment study (FACTS). A randomized double-blind placebo controlled clinical trial. Arthritis Rheum. 2011 ; 63 : 3383-91 [IF 8.4], PMID : 21898340
  • Gabay C., Bel M., Combescure C., Ribi C., Meier S., Posfay-Barbe K., Grillet S., Seebach J.D., Kaiser L., Wunderli W.,Guerne P.-A., Siegrist C.-A.: Impact of Synthetic and Biological Disease Modifying Antirheumatic Drugs on Antibody Responses to the ASO3-Adjuvanted Pandemic Influenza Vaccine. A prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum 2011; 63: 1486-96 [IF 8.4], PMID: 21384334
  • Kyburz D., Gabay C., Michel B.A., Finckh A. : The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology 2011; 50 : 1106-10 [IF : 4.24], PMID : 21258051$ Jha R, Srivastava P, Salhan S, Finckh A, Gabay C, Mittal A, Bas S. Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection. Microbes Infect. 2011 13(2): 167-78 [IF 3.1], PMID: 21034849
  • Genevay S, Cedraschi C, Courvoisier DS, Perneger TV, Grandjean R, Griesser AC, Monnin D.: Work related characteristics of back and neck pain among employees of a Swiss University Hospital. Joint Bone Spine 2011 Jul; 78(4): 392-7 [IF 2.25]. PMID: 21093343

Articles de revues publiés ou acceptés dans des journaux à politique éditoriale

  • Palmer G. and Gabay C. : IL-33 biology with potential insights into human diseases. Nat Rev Rheumatology 2011; 7 : 321-9 [IF 6.4]

 

2010

Articles originaux publiés dans des journaux à politique éditoriale

  • Lamacchia C., Palmer G., Bischoff L., Rodriguez E., Talabot-Ayer D., Gabay C. : Distinct roles of hepatocyte and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice.
  • Lamacchia C., Palmer G., Seemayer C.A., Talabot-Ayer D., Gabay C.: Enhanced Th1 and Th17 rsponses and arthritis severity in mice with a deficiency of myeloid cell-specificic interleukin-1 receptor antagonist. Arthritis Rheum. 2010; 62 (2):452-462. [IF: 7.4]. PMID: 20112392
  • Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA., Finckh A., Lovis C., Mach F., Hochstrasser D., Roux-Lombard P., and Gabay C.: Anti-apolipoprotein A-1 IgG predict major cardiovascular events in patients with rheumatoid arthritis. Arthritis & Rheumatism, 2010 Sept:62(9):2640-50. [IF 7.33]. PMID: 20506304
  • Singwe-Ngandeu M, Finckh A., Bas S., Tiercy JM and Gabay C.: Diagnostic value of anti-cyclic citrullinated peptides and anti-citrullinated fibrinogen antibodies and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arthritis Res Ther. 2010 Mar2;12(2):R36 [IF 4.27]. PMID: 20196860
  • Nissen MJ, Gabay C, Scherrer A, and Finckh A.: The effect of alcohol on radiographic progression in rheumatoid arthritis. Arthritis Rheum. 2010 may; 60(5):1265-72 [IF 7.33]. PMID: 20213811
  • Finckh A, Ciurea A, Brulhart L, Moeller B, Walker UA, Courvoisier d, Kyburz D and Gabay C.: Which subgroup of rheumatoid arthritis patients benefit most from switching to Rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent? Ann Rheum Dis. 2010 Feb;69 (2):387-93 [IF 8.11]. PMID: 19416802
  • Bas S., James R.W., Gabay C.: Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins. BMC Immunol. 2010 Sep 16;11:46, [IF 3.00]. PMID: 20846396
  • Genevay S, Viatte S, Finckh A, Zufferey P, Balagué F and Gabay C.: Adalimumab in severe acute sciatica. A randomized controlled trial. Arthritis & Rheum. 2010 Aug; 62 (8) : 2339-46 [IF 7.33]. PMID : 20506391

Articles de revues publiés dans des journaux à politique éditoriale

  • Genevay S, Atlas S, Katz J.N: Variation in eligibility criteria from studies of radiculopathy due to a herniated disc and neurogenic claudication due to lumbar spinal stenosis: A structured literature review. Spine 2010 Apr 1;35(7) [IF 2.499]. PMID: 20228710
  • Finckh A.: Comparative effectiveness of rheumatoid arthritis therapies Curr Rheumatology Rep 2010, vol 12(5), Jul 23, 348-354. [IF 2.70]. PMID: 20652775
  • Gabay C., Lamacchia C., Palmer G.: IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010 Apr; 6(4):232-41 [IF 5.67]. PMID: 20177398